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Cognitive abilities vary among people. About 40–50%
of this variability is due to general intelligence (g),
which reflects the positive correlation among indi-
viduals’ scores on diverse cognitive ability tests. g is
positively correlated with many life outcomes, such
as education, occupational status and health, moti-
vating the investigation of its underlying biology. In
psychometric research, a distinction is made between
general fluid intelligence (gF) – the ability to reason in
novel situations – and general crystallized intelligence
(gC) – the ability to apply acquired knowledge. This
distinction is supported by developmental and cog-
nitive neuroscience studies. Classical epidemiological
studies and recent genome-wide association studies
(GWASs) have established that these cognitive traits
have a large genetic component. However, no robust
genetic associations have been published thus far due
largely to the known polygenic nature of these traits
and insufficient sample sizes. Here, using two GWAS
datasets, in which the polygenicity of gF and gC traits
was previously confirmed, a gene- and pathway-based
approach was undertaken with the aim of characterizing
and differentiating their genetic architecture. Pathway
analysis, using genes selected on the basis of relaxed
criteria, revealed notable differences between these two
traits. gF appeared to be characterized by genes affect-
ing the quantity and quality of neurons and therefore
neuronal efficiency, whereas long-term depression (LTD)
seemed to underlie gC. Thus, this study supports the
gF–gC distinction at the genetic level and identifies
functional annotations and pathways worthy of further
investigation.
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A large proportion (40–50%) of interindividual variabil-
ity in cognitive abilities is due to general intelligence (g),
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a quantitative trait that reflects the positive correlation
among an individual’s scores on diverse cognitive ability tests
(Deary 2012; Spearman 1904). A high g score is associated
with many favorable life outcomes (Deary & Batty 2011).
Psychometric research distinguishes between general
fluid intelligence (gF) – the ability to reason in novel situa-
tions – and general crystallized intelligence (gC) – the ability
to apply acquired knowledge and learned skills (Carroll 1993;
Cattell 1963). Although gF and gC are correlated at least 50%
based on twin studies (Wainwright et al. 2005) and more
so early and late in life (Li et al. 2004), developmental and
cognitive neuroscience studies largely support the distinction
between them. In normal aging, gF declines earlier and more
rapidly than gC (Craik & Bialystok 2006; Salthouse 2004);
in development, measures of verbal (gC) and non-verbal
(gF) intelligence correlate differently with changes in brain
structure (Ramsden et al. 2011). Furthermore, gF is closely
associated with fronto-parietal and anterior cingulate brain
networks, whereas gC is dependent on posterior frontal
and temporal regions (Barbey et al. 2012; Glascher et al.
2009; Jung & Haier 2007; Woolgar et al. 2010). Finally, at
the population level, large gains in performance have been
observed for tests that are strongly associated with gF, but
not with gC (Flynn 2007).
More than half of the variability in intelligence tests
is attributable to additive genetic effects (Deary et al.
2009a; Lee et al. 2010; Plomin & Spinath 2004). In a recent
genome-wide association study (GWAS), 40% and 51% of
the phenotypic variability in gC and gF, respectively, could be
accounted for by genetic variants in linkage disequilibrium
(LD) with common single nucleotide polymorphisms (SNPs)
(Davies et al. 2011), providing a lower-bound estimate of
the narrow-sense heritability of these traits. Furthermore,
using only SNP data, ∼1% of the variance in intelligence test
scores in a sample could be predicted in an independent
sample (Davies et al. 2011). However, at the single-marker
level, no robust genetic association with intelligence has
yet been published, consistent with the observation that
the effect of individual SNPs may be too weak to be
detected in complex polygenic traits using the classical
genome-wide P ≤5×10−8 threshold (Wellcome Trust Case
Control Consortium 2007) on the sample sizes currently avail-
able (International Schizophrenia Consortium et al. 2009).
Therefore, relaxing the significance criteria and exploiting the
polygenic signal by going beyond the traditional single-marker
approach to gene- and pathway-based methods may offer
more power (Neale & Sham 2004) and insight into the
biological processes underlying these traits (Wang et al.
2010).
The polygenic architecture of gF and gC was previously
confirmed using the Cognitive Aging Genetics in England
and Scotland (CAGES) cohort as the discovery sample and
the Norwegian Cognitive NeuroGenetics (NCNG) adult lifes-
pan sample for replication (Davies et al. 2011). Here, using
the same datasets, we combine single-marker, gene- and
pathway-based approaches to characterize the genetic archi-
tecture of gF and gC with respect to known biological
processes.
Materials and methods
GWASs: genotypes and phenotypes
The genotype and phenotype protocols and the samples have been
described previously (Davies et al. 2011; Espeseth et al. 2012). All
participants gave written consent before the study started. All proce-
dures were conducted according to the tenets of the Declaration of
Helsinki and approved by the relevant Research Ethics Committees.
An overview of the genotype and phenotype protocols in the discov-
ery and replication samples is provided below, with further details
available in the original publications.
Discovery GWAS
The final NCNG GWAS consisted of 554 225 SNPs genotyped in a
homogenous Norwegian sample of 670 individuals (457 females),
ranging from 18 to 79 years of age (M =47.6; SD=18.3) (Espeseth
et al. 2012). Participants completed a battery of psychometric tests,
assessing general cognitive ability, memory, attention and speed of
processing. The protocol was approved by the Regional Committee
for Medical and Health Research Ethics, Southern Norway (project
ID: S-03116). DNAs were genotyped on the Illumina Human610-Quad
Beadchip. Quality control was performed with the ‘check.marker’
function of the R package GenABEL (Aulchenko et al. 2007). Indi-
viduals were excluded based on relatedness (‘ibs.threshold’=0.85),
heterogeneity, unresolved sex discrepancies and call rate≤0.97.
Population structure was assessed by multidimensional scaling
(MDS) analysis (using 100000 random SNPs), removing outlying
samples with possible recent non-Norwegian ancestry. No additional
adjustment for population structure was performed because of the
homogeneity of the sample (Espeseth et al. 2012). Single nucleotide
polymorphisms with a call rate≤0.95, minor allele frequency≤0.01
and Hardy–Weinberg equilibrium (exact test) P-value≤0.001 were
excluded.
Replication GWAS
The CAGES sample consists of five cohorts, the Lothian Birth Cohorts
of 1921 (Deary et al. 2004, 2009b) and 1936 (Deary et al. 2007)
(LBC1921, LBC1936), the Aberdeen Birth Cohort of 1936 (ABC1936)
(Deary et al. 2004, 2009b) and the Manchester and Newcastle Lon-
gitudinal Studies of Cognitive Aging Cohorts (Rabbitt et al. 2004).
The final GWAS dataset consisted of 549 692 SNPs genotyped in
3511 healthy individuals (2115 females) with detailed cognitive abil-
ity measurements taken in middle to older adulthood (mean age
ranged from 64.6 in the ABC1936 to 79.1 in LBC1921; overall age
range: 44–93) (Davies et al. 2011). Ethical approval was obtained from
the relevant Research Ethics Committees. Individuals were excluded
based on unresolved gender discrepancy, coefficient of related-
ness>0.025 (based on 549692 autosomal SNPs), call rate≤0.95 and
evidence of non-Caucasian descent as determined by MDS analysis
(Davies et al. 2011). Single nucleotide polymorphisms were included
if they met the following conditions: call rate≥0.98, minor allele fre-
quency≥ 0.01 and Hardy–Weinberg equilibrium test with P ≥0.001.
Population structure was assessed by MDS analysis, and four MDS
components were fitted as covariates to correct for any population
stratification that might be present.
Cognitive phenotypes
Different measures of gF and gC were employed for each of the
five CAGES samples and the NCNG sample (Davies et al. 2011). In
general, the different tests of gF aimed to assess each individual’s
capacity to reason logically and solve problems in novel situations,
relatively independently of acquired knowledge. gF employs aspects
of processing speed, attention, memory and executive function.
The gC tests were vocabulary-based, assessing each individual’s
semantic knowledge. All measures were corrected for sex (with the
exception of the CAGES Manchester and Newcastle gF, which was
derived separately for males and females) and age. The standardized
residuals were then extracted and used as the trait measures in all
subsequent analyses. In the NCNG, of the 670 individuals, 629 and
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643 had scores for gF and gC, respectively. In the CAGES, of the 3511
individuals, 3400 and 3482 had scores for gF and gC, respectively.
Analyses
Construction of gene lists
A ‘bottom-up’ approach (Liu et al. 2007) was undertaken. Both
single-marker and gene-based association analyses were performed,
testing SNPs and genes individually first in order to construct a list
of genes that would then be subjected to pathway analysis, via Inge-
nuity Pathway Analysis (IPA), to identify over-represented functions
and/or pathways. For each of gF and gC, genetic factors that showed
evidence of association in the NCNG were identified and filtered
further based on evidence of replication in the CAGES. Single-marker
and gene-based statistical methods and thresholds were selected
and applied, as appropriate, with the aim of controlling the Type II
(false-negative) as well as the inversely related Type I (false-positive)
error rates, incorporating instead prior biological knowledge to the
interpretation of the findings and generating testable hypotheses for
further investigation (Lieberman & Cunningham 2009; Williams &
Haines 2011).
The LDsnpR tool (Christoforou et al. 2012a) was used to (1) anno-
tate individual SNPs and (2) assign SNPs to genes for the gene-based
analyses. Single nucleotide polymorphisms were assigned to genes
(Ensembl 54 definitions) if they were located physically within
the boundaries of the gene (±10 kb) or if they were in high LD
[r2 ≥ 0.80 based on HapMap CEU (http://hapmap.ncbi.nlm.nih.gov/)]
with another SNP located within the boundaries of the gene
(±10 kb).
Single-marker analyses. In the NCNG sample, association
between individual SNP alleles and cognitive phenotypes was
tested using linear regression analysis (1 d.f. coefficient t-test), as
implemented in PLINK (Purcell et al. 2007). The CAGES GWAS data
comprised the inverse variance weighted model ‘meta P-values’
produced in the original CAGES five-sample meta-analysis (i.e. as
reported by Davies et al. 2011). A meta-analysis of the CAGES
and NCNG single-marker allele P-values was performed on the
overlapping SNPs, using an inverse variance weighted model, as
implemented in METAL (Willer et al. 2010).
All SNPs with an asymptotic nominal P-value of ≤0.05 in the
NCNG were then mined for replication in the CAGES GWAS data.
As advised in Konig (2011), positive single-marker replication was
determined on the basis of P ≤0.05 and the same direction of effect
in both the NCNG and CAGES samples, resulting in a meta-analysis
P-value that is more significant than either of the original P-values.
Using LDsnpR, all SNPs that replicated were annotated, where
possible, with a gene name or Ensembl identifier and taken forward
for pathway-based analysis by IPA.
Gene-based analyses. All 554 225 SNPs in the NCNG GWAS
were assigned, where possible, to genes using LDsnpR. For each
gene containing an SNP, association was assessed by applying
PLINK’s permutation-based set test on the LDsnpR-generated sets.
Gene-based statistics generated by permutation-based methods
automatically account for potential confounding factors, such as LD
structure and gene length or SNP number, through the generation of
an empirical null distribution (Liu et al. 2010). As the true underlying
genetic architecture of these traits is unknown, three different mod-
els were tested to obtain a gene-based association score (Lehne et al.
2011):
1 The ‘minimum P-value’ (minP) model, which assigns to each
gene the association statistic, or P-value, of the most signifi-
cant SNP in the gene, assumes that a single SNP within the
gene contributes to the phenotype.
2 The ‘all P-values’ model, which assigns to each gene the
mean association statistic of all the SNPs in the gene,
assumes that all or most SNPs within the gene contribute to
the phenotype.
3 The ‘P ≤ 0.05 threshold’ model, which assigns to each gene
the mean association statistic of all SNPs within the gene that
have a P ≤0.05, assumes that only a few or a subset of SNP
contribute to the phenotype.
The P-values were computed based on 10000 permutations, and
the lowest of the three permuted P-values was retained as the
gene-based P-value for each gene. No additional correction was
applied to the gene-based score to account for testing the three
models because of high correlation between the tests. Genes with
gene-based permuted P ≤0.05 were mined for replication in the
CAGES.
In order to preserve the Type II error rate, the replication criteria in
the CAGES were relaxed to include any gene that contained at least
one SNP with a ‘meta-P’≤0.05, ensuring that significance under
any genetic architecture was captured. In the NCNG, for example,
all genes with a minimum gene-based permuted P ≤0.05 contained
at least one SNP with a P ≤0.05 (data not shown). This replication
criterion of at least one SNPwith a ‘meta-P’≤0.05 is equivalent to the
unadjusted minimum P-value approach. Thus, the CAGES SNPs were
first assigned to genes using LDsnpR, as described above, and the
genes were scored using the minimum P-value approach, assigning
to the gene the P-value of the most significant SNP in that gene
(without further adjustment). All genes that were selected from the
NCNG and that also replicated in the CAGES (i.e. meta-P ≤ 0.05) were
taken forward for analysis with IPA. Finally, after the relevant gene
lists were pruned for LD on the basis of their association signals
and position, the hypergeometric distribution, as implemented in
www.geneprof.org/GeneProf/tools/hypergeometric.jsp, was used to
assess whether the number of genes replicating in the CAGES was
greater than expected by chance.
Construction of gene lists – stringent replication criteria.
As the aforementioned single-marker and gene-based replication
criteria in the CAGES are prone to inflating the Type I error rate due
to gene-length bias, the robustness of the subsequent main IPA
findings was assessed by re-running IPA on gene lists constructed
using more stringent statistical thresholds and methods. First, for
the single-marker analysis, only genes tagged by the SNPs that
met the previously described replication criteria and resulted in a
meta-analysis P ≤1× 10−5, as supported by the National Human
Genome Research Institute GWAS catalog (Welter et al. 2014), were
taken forward for IPA analysis. For the gene-based analysis, replica-
tion in the CAGES was determined using two gene-scoring methods,
which accounted for the number of SNPs per gene and, critically, for
LD without requiring genotype-level data. The first method scored
each gene with the most significant P-value (i.e. the minP approach),
adjusting for the number of SNPs using a modified Sidak’s correction
(Saccone et al. 2007). This approach has been shown to perform
as well as regression-based methods (Christoforou et al. 2012a;
Segre et al. 2010). The second approach was comparable to the
regression-based ‘all P-values’ model described above, combining all
SNPs mapped to the gene using Brown’s approximation method, as
implemented in PLINK (Moskvina et al. 2011; Purcell et al. 2007). The
NCNG genotype data was used to estimate the LD between SNPs.
Thus, the genes with gene-based permuted P ≤0.05 in the NCNG,
which met a P-value of ≤0.05 with either of these two methods in
the CAGES, were subjected to IPA analysis.
Ingenuity Pathway Analysis
Genes that showed evidence of association in the NCNG and of repli-
cation in the CAGES based on either the single-marker and/or the
gene-based analysis were selected for pathway analysis with IPA
(Ingenuity® Systems, www.ingenuity.com) to identify the most rel-
evant biological functions and pathways. Ingenuity Pathway Analysis
gathers information from published data from ∼3600 peer-reviewed
journals regarding relationships between genes and proteins. The
information is updated weekly, manually curated and stored within
the Ingenuity® Knowledge Base, which is then queried during an anal-
ysis to identify specific biological functions, or ‘function annotations’,
and pathways enriched within the submitted gene list.
In this study, the Ensembl 54 gene identifiers were uploaded into
IPA and mapped, if possible, to their corresponding object in the
Ingenuity® Knowledge Base (Genes Only). A ‘Core Analysis’ was
Genes, Brain and Behavior (2014) 13: 663–674 665
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performed, including both direct and indirect relationships and using
all available data sources in all species available. Molecules and/or
relationships that were either experimentally observed or predicted
with high confidence were considered. For the main analyses, which
aimed to differentiate gF and gC as it relates, most relevantly, to the
nervous system, tissues and primary cells were restricted to those
of the nervous system, and cell lines were restricted to those of
the central nervous system. Additional analyses were performed to
evaluate the robustness and relevance of the main findings, including
(1) re-running the IPA having excluded genes known to be extensively
studied to assess the possibility of publication bias driving the main
findings and (2) re-running the IPA having included all tissues and cell
lines, except those specific to cancer, to assess the relevance of the
main findings in the context of more global annotation.
In particular, we focused on the significant function annotations.
The function annotations are organized based on Ingenuity® Ontol-
ogy, which consists of a manually built and maintained hierarchical
data structure of hundreds of thousands of unique classes. As part
of the ‘Core Analysis’, IPA performs a Fisher’s exact test (FET) to
determine whether the submitted gene list consists of genes of a par-
ticular function annotation more than expected by chance, given the
proportion of genes of that particular function annotation in the entire
Ingenuity Knowledge Base. It also uses the Benjamini–Hochberg
(BH) multiple-testing correction method to adjust for the number
of ontologies tested, providing a false discovery rate for a particular
function annotation. In this study, all functional annotations with
an FET P ≤0.05 (and corresponding BH P ≤0.25) were considered
significant.
Results
Construction of gene lists
Single-marker analyses
A total of 554 225 SNPs were tested for allelic association
to gF (N =629 individuals) and gC (N =643 individuals) in
the NCNG sample. As these GWAS data results were not
presented in the previous study (Davies et al. 2011), the tra-
ditional SNP-level diagnostics and results are provided in
the Supporting Information (Fig. S1 and Dataset S1). The
genomic inflation factor was 1 for both gF and gC (Fig. S1),
indicating that the data did not suffer from population strat-
ification or other systematic bias. When mining the CAGES
data, 816 SNPs in gF and 884 SNPs in gC met the repli-
cation criteria of P ≤0.05 and the same direction of effect
(Dataset S1). Using the LD-based binning approach imple-
mented in LDsnpR (Christoforou et al. 2012a), 481 (59%) of
the gF SNPs and 549 (62%) of the gC SNPs were assigned to
Ensembl 54 genes. 159 gF SNPs and 160 gC SNPs mapped
to more than one gene on the basis of LD. As it is not possi-
ble to identify the true source of the association on the basis
of the SNP P-value alone (Christoforou et al. 2012a,2012b),
all genes were retained for pathway analysis. The significant
function annotations or pathways were subsequently manu-
ally examined to ensure that they did not consist of clusters
of genes representing the same genetic association signal.
Thus, 503 and 530 Ensembl 54 genes for gF and gC, respec-
tively (Dataset S1), were taken forward for IPA analysis. A
total of 171 (34%) of the gF genes and 212 (40%) of the gC
genes were implicated by more than one replicated SNP.
Gene-based analyses
A gene-based approach was also used to identify candidate
genes for pathway analysis, allowing for locus heterogeneity
and the aggregation of multiple weaker association signals.
In the NCNG, of the 34 109 eligible Ensembl 54 gene entries,
2698 and 2615 met the nominal significance threshold of
set-based permuted P ≤0.05 in gF and gC, respectively
(Dataset S2). Of these, 841 gF genes and 920 gC genes
had a minimum P-value gene-based score of ≤0.05 in the
CAGES (Dataset S2). After the relevant gene lists were first
pruned for LD based on position and association signal,
resulting in 607 and 652 relatively independent association
signals for gF and gC, respectively, the number of genes
showing evidence of replication was more than expected
by chance for gC (hypergeometric P = 4.5×10−4), but not
for gF (hypergeometric P =0.25). The 841 gF genes and
920 gC genes were added to the list of genes identified by
single-marker analysis and taken forward for IPA.
Ingenuity Pathway Analysis
Figure 1 summarizes the number of SNPs and genes identi-
fied in each analysis and the relevant corresponding overlaps.
A total of 1182 genes for gF and 1294 genes for gCwere iden-
tified through both the single-marker and gene-based analy-
ses and subjected to IPA analysis. Of these genes, 853 for gF
and 893 for gC were identified by their Ensembl Gene iden-
tifier in the IPA database (i.e. ‘IPA Ready’ genes; Dataset S3)
and were thus available for pathway analysis. A total of 117
genes were in common between the two traits.
Figure 1: Summary of SNP- and gene-based analyses and
corresponding numbers of genes identified for IPA for both
gF (left) and gC (right). The boxed numbers in the centre
represent the number of genes identified as a result of the
SNP-based analyses (from top, down), the gene-based analyses
(from bottom, up), the resulting total number of unique genes
submitted to IPA and the number of relevant overlapping genes
(in parentheses). * indicates that the GWAS SNPs were assigned
to genes by LDsnpR.
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IPA’s ‘Core Analysis’ was run on the two lists of genes,
restricting the analysis to tissues and cell lines related to
the nervous system. Function annotations that were signif-
icantly enriched with an FET P ≤0.05 and a BH P ≤ 0.25,
which account for all of the function annotations tested, were
declared significant and evaluated. For both traits, function
annotations involved in the biological function ‘Nervous Sys-
tem Development and Function’ were the most common,
accounting for >25% of the function annotations. These
were followed by annotations involved in ‘Cell-to-Cell sig-
naling’ and ‘Cellular Assembly and Organization’ in both gF
and gC (∼8%) (Dataset S3). However, it is important to note
that some function annotations are categorized under multi-
ple biological functions, resulting in redundancy in the data
(e.g. ‘axonogenesis’ appears under ‘Nervous System Devel-
opment and Function’, ‘Cell Morphology’, ‘Cellular Func-
tion and Maintenance’, ‘Cellular Assembly and Organiza-
tion’ and ‘Tissue Development’). When considering only the
non-redundant function annotations, specifically those iden-
tified on the basis of at least two genes from the inputted
gene list, 85 and 54 function annotations were identified as
significantly enriched in gF and gC, respectively (Dataset S3).
Only four function annotations were enriched in both gF
and gC, including ‘microtubule dynamics’ and ‘chemotaxis
of neurons’, which could be generally categorized as archi-
tectural features of neuronal development. The set of genes
leading to the enrichment of these overlapping annotations in
gF was different to that in gC (Table 1), except for the ‘migra-
tion of GABAergic neurons’ annotation which was attributed
to the same two genes in gF and gC.
The most statistically significant functional annotations
were identified in gC. ‘Synaptic depression’ ranked at the
top (FET P =2.9×10−6; BH P =0.0015), with the related
‘long-term depression’ in general (LTD; FET P = 2.0×10−5;
BH P =0.0052) and LTD of specific cells (Table 2), all of which
are highly related as indicated by the composite genes. ‘Guid-
ance of axons’ and ‘schizophrenia’ were also significantly
enriched in gC (FET P = 4.8×10−4 and 0.042, respectively),
with the former also ranking third (Table 2 and Dataset S3).
The general functional enrichment profiles of gF and gC
were different. No function emerged as notably significant
in gF, a finding which was further emphasized by the ‘flat’
multiple-testing corrected BH P-value of 0.18 for all sig-
nificant annotations. The most significantly enriched func-
tional annotation identified was ‘synaptic fatigue of synapse’
(FET P =0.0021), followed by ‘apoptosis of spinal cord cells’
(FET P =0.0041) and ‘inhibition of neurons’ (FET P = 0.0053)
(Table 3). However, the predominance of function annota-
tions relating to ‘quantity’, particularly of neurons and of
other structures of the nervous system, was notable (Table 3;
Fig. S2; Dataset S3). Other functions were related to the
quantity (e.g. formation, loss, survival and apoptosis), quality
(e.g. synaptic fatigue, degradation, atrophy and myelination)
or morphology of neurons or related structures. Long-term
potentiation (LTP) was another repeated function for gF (Fig.
S2). One gene, brain-derived neurotrophic factor (BDNF ),
which showed gene-based association with gF (Dataset S2),
contributed to the enrichment of several significant func-
tion annotations for gF (Table 3 and Dataset S3). As BDNF
is one of the most extensively studied genes in the field Ta
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Table 2: Top 25 IPA FAs for gC
Function FA FET P-value
BH
P-value
No. of
genes Genes
Synaptic
depression
Synaptic depression 2.9× 10−6 0.0015 13 ADCY5, ADCY8, CNR1, DRD5,
EPHB1, EPHB2, GRM7, LRRC7,
MTOR, PRKCA, RYR3, ST8SIA4,
SYNJ1, (ITSN1)
LTD LTD 2.0× 10−5 0.0052 11 ADCY5, ADCY8, CNR1, DRD5,
EPHB2, GRM7, LRRC7,MTOR,
PRKCA, RYR3, ST8SIA4
Guidance Guidance of axons 4.8× 10−4 0.061 16 ALCAM, ANK3, CDH4, CNTN4,
DCC, EPHB1, EPHB2, ERBB4,
EXT1, GLI3, KLF7, NFASC,
PLXNA2, SEMA3A, SLIT1, SLIT2
LTD LTD of cells 4.8× 10−4 0.061 6 ADCY5, CNR1, DRD5, PRKCA,
RYR3, ST8SIA4
LTD LTD of brain cells 7.2× 10−4 0.075 5 ADCY5, CNR1, PRKCA, RYR3,
ST8SIA4
LTD LTD of neurons 0.0013 0.11 5 ADCY5, CNR1, DRD5, RYR3,
ST8SIA4
Assembly Assembly of olfactory
cilia
0.0020 0.13 3 BBS10, PCDH15, VANGL2
LTD LTD of corticostriatal
neurons
0.0023 0.13 2 ADCY5, CNR1
Positioning Positioning of cholinergic
neurons
0.0023 0.13 2 SLIT1, SLIT2
Contact
repulsion
Contact repulsion 0.0034 0.17 3 DCC, SEMA3A, SLIT2
Chemotaxis Chemotaxis of neurons 0.0037 0.17 4 EPHB2, GFRA1, SEMA3A, SLIT2
Development Development of optic
chiasm
0.0068 0.22 2 SLIT1, SLIT2
Size Size of lateral cerebral
ventricle
0.0068 0.22 2 ANK2, NRG1 (includes EG:112400)
Apoptosis Apoptosis of sensory
neurons
0.0076 0.22 3 CDKN2D, HIPK2, KLF7
Metabolism Fatty acid metabolism 0.010 0.22 5 DAB1, ERBB4, NRG1, SEMA3A,
ST8SIA1
Abnormal
morphology
Abnormal morphology of
nervous system
0.013 0.22 2 CNR1, UHRF1
Formation Formation of
oligodendrocytes
0.013 0.22 2 ERBB4, NRG1
Guidance Guidance of
thalamocortical axons
0.013 0.22 2 SLIT1, SLIT2
Migration Migration of GABAergic
neurons
0.013 0.22 2 GFRA1, SLIT1
Pathfinding Pathfinding of axons 0.013 0.22 2 DCC, EXT1
Chemotaxis Chemotaxis of cells 0.014 0.22 5 EPHB2, FPR2, GFRA1, SEMA3A,
SLIT2
Development Development of
diencephalon
0.014 0.22 3 SIM2, SLIT1, SLIT2
LTD LTD of synapse 0.018 0.22 3 CNR1, GRM7,MTOR
Synthesis Synthesis of fatty acid 0.020 0.22 4 DAB1, ERBB4, NRG1, SEMA3A
Synthesis Synthesis of lipid 0.020 0.22 6 CNR1, DAB1, ERBB4, NRG1,
SEMA3A, ST8SIA1
For each general function, the specific FA is shown together with its corresponding FET P-value, the BH multiple-testing corrected
P-value, the number of genes and the symbols of the genes responsible for the enrichment signal in the FA. The functions and FAs that
remained significant in the IPA analysis of the genes that passed the more stringent criteria are underlined. The gene(s) in parentheses
are those that emerged from the more conservative analysis.
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Table 3: Top 25 IPA FAs for gF
Function FA
FET
P-value
BH
P-value
No. of
genes Genes
Synaptic fatigue Synaptic fatigue of synapse 0.0021 0.18 2 BDNF, SYN3
Apoptosis Apoptosis of spinal cord cells 0.0041 0.18 4 BAX, BCL2, BDNF, FAM134B
Inhibition Inhibition of neurons 0.0053 0.18 4 BDNF , NPPA, NPPB, NRG1
Development Development of sensory nervous
system
0.0062 0.18 2 BDNF, KIF1A
Inhibition Inhibition of pyramidal neurons 0.0062 0.18 2 BDNF, NRG1
Concentration Concentration of arachidonic
acid
0.0062 0.18 2 DGKE , KNG1
Endocytosis Endocytosis of synaptic
vesicles
0.0067 0.18 4 AMPH, CABIN1, ITSN1, SNCA
Damage Damage of cortical neurons 0.0067 0.18 3 BAX, BDNF, GRIN3A
Quantity Quantity of central nervous
system cells
0.0090 0.18 9 ACHE , AVPR1B, CCND2, EGFR, GDA,
IGFBP6, LEF1, LHX5, TSC1
LTP LTP 0.0092 0.18 13 B3GAT1, BDNF , CDH1, CHRNA7 , CYP19A1,
DGKE , LRP1, LRP8, NRG1, PLG, SNCA,
VAV2, VAV3
Apoptosis Apoptosis of dorsal root
ganglion cells
0.0093 0.18 3 BAX , BCL2, FAM134B
Mobilization Mobilization of Ca2+ 0.0093 0.18 3 BDNF, PROK2, TRPV1
Morphogenesis Morphogenesis of neurites 0.0097 0.18 22 ACHE , ATXN10, BDNF , BSN, CNTN4,
CNTNAP2, CTNNA2, CTNND2,
CYP19A1, EGFR, GDA, IGF1R,MAPK8,
NRG1, PRKG1, PTPRM , RND1, SGK1,
SLC18A3, SLIT1, SYNE1, UHMK1, (TLR7)
Growth Growth of dendrites 0.0099 0.18 5 BDNF , CTNND2, CYP19A1, NRG1, SLIT1
Morphology Morphology of dendrites 0.0099 0.18 5 BDNF , DISC1, GRIN2D, NPAS3, NRG1
Quantity Quantity of acetylcholine 0.012 0.18 2 ACHE , SLC18A3
Survival Survival of dorsal root ganglion 0.012 0.18 2 BAX, BDNF
Synaptogenesis Synaptogenesis of brain cells 0.012 0.18 2 BDNF, CYP19A1
LTP LTP of granule cells 0.012 0.18 2 BDNF, DGKE
Sensitization Sensitization of neurons 0.012 0.18 2 BDNF, KNG1
Migration Migration of GABAergic
neurons
0.012 0.18 2 GFRA1, SLIT1
Quantity Quantity of astrocytes 0.012 0.18 4 ACHE , EGFR, IGFBP6, TSC1
Cell viability Cell viability of motor neurons 0.015 0.18 5 BAX, BCL2, BDNF, GFRA1, REG3G
Loss Loss of motor neurons 0.016 0.18 3 BCL2, BDNF, GFRA1
Quantity Quantity of nerve ending 0.016 0.18 3 BDNF, SLC18A3, SNCA
For each general function, the specific FA is shown together with the corresponding FET P-value, the BH multiple-testing corrected
P-value, the number of genes and the symbols of the genes responsible for the enrichment signal in the FA. FAs that remained significant
after excluding BDNF are in bold. The functions and FAs that remained significant in the IPA analysis of the genes that passed the more
stringent criteria are underlined. The gene(s) in parentheses are those that emerged from the more conservative analysis.
(Green et al. 2008), it could bias the IPA results, which are
based on peer-reviewed publications. However, when IPA
was run without BDNF , most of the significant findings with-
stood its exclusion (Table 3 and Dataset S3), and the general
functional enrichment profile observed in gF was preserved.
A manual examination of the chromosomal positions of the
sets of genes leading to the enrichment of the significant
annotations listed in Tables 1–3 ensured that these signifi-
cant enrichments are due to independent association signals
and not due to the same association signal represented by
clusters of genes in LD.
In order to gauge the robustness of the above findings
in the absence of the gene-length bias that may have
been introduced with the relaxed replication criteria, the
CNS-specific IPA analysis was also performed on gene lists
constructed on the basis of more stringent replication crite-
ria. For gF, the single-marker analysis identified two genes
which contained replicated SNPs that met the meta-analysis
P ≤1×10−5 threshold (Dataset S1). The gene-based anal-
ysis identified 178 genes with gene-based P ≤0.05 using
either the modified Sidak approach or Brown’s approximation
method (Dataset S2). Together, this resulted in a total of 180
genes available for IPA analysis for gF. For gC, 5 and 224
genes were identified via the single-marker and gene-based
analyses, respectively, resulting in 225 unique genes avail-
able for IPA analysis. Nine genes were common to both
gF and gC.
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The IPA results emerging from the abridged gene lists were
not as impressive in terms of the number of significant unique
function annotations (N = 26 and 8 for gF and gC, respec-
tively) and in terms of their general enrichment profiles for
gF and gC (Dataset 3). Also, for both traits, different function
annotations emerged as most significant, namely ‘neuritoge-
nesis’ for gF (FET P =2.8×10−4) and ‘hypoplasia of cerebel-
lar vermis’ (FET P = 0.0015) (Dataset 3). However, the main
functions that were found to distinguish gF from gC in the
original, less conservative analysis remained significant. ‘LTD’
and ‘synaptic depression’ remained unique to gC albeit at a
reduced significance level (FET P =0.018 and 0.047, respec-
tively) (Table 2 and Dataset 3). For gF, functions which related
to quantity, quality or morphology of neurons and synapses
still predominated. These included ‘quantity’, ‘morphogene-
sis’ and ‘development’ of neurons, synapses and other brain
structures (Dataset 3). No function annotations were com-
mon to both traits in this analysis.
Finally, returning to the original gene lists based on the
relaxed criteria, IPA was run again on both traits, using infor-
mation from all cell lines, with the exception of cancer cell
lines, in the Ingenuity® Knowledge Base. This helped to
evaluate the primary CNS-restricted results relative to more
global annotation, to identify annotations that may be related
to cognitive ability and to enable the inclusion of published
studies of brain-related traits that were executed in non-CNS
cell lines, such as lymphoblastoid cell lines (Gladkevich et al.
2004). The significance of the original, CNS-restricted find-
ings was largely unaffected. The most significant annotations
for gF in this analysis fell under the disease and disorder cate-
gory of ‘Cardiovascular Disease’ (e.g. ‘vascular disease’, FET
P = 7.1×10−6; Dataset S3). In addition, the function annota-
tions ‘development of brain’, ‘behavior’, ‘cognition disorders’,
‘cognitive impairment’ and ‘schizophrenia’ were also signifi-
cantly enriched in gF (Dataset S3). For gC, ‘synaptic depres-
sion’ remained the most significant annotation. However, it
was followed by the ‘Cardiovascular Disease’ function anno-
tation ‘coronary artery disease’ (FET P =1.8×10−6; Dataset
S3). The significance of the enrichment of ‘schizophrenia’ also
marginally improved (from FET P =0.042 to FET P = 0.026,
Dataset S3).
Discussion
Novel polygenic approaches to analyzing GWAS data have
greatly improved our understanding of complex traits and
have captured more of the ‘hidden heritability’ (Davies et al.
2011; Maher 2008; Manolio et al. 2009; Visscher et al. 2012)
but have failed to identify the markers or genes impli-
cated. Pathway-based techniques are complementary poly-
genic methods that support biological analysis of GWAS data.
Gene-based methods, which are ideal for pathway-based
approaches (Liu et al. 2010), permit the aggregation of SNPs
of smaller effect and test the gene as a whole, potentially
increasing power (Neale & Sham 2004). These analyses are
also more permissive to locus heterogeneity, where multiple
independent variants within a locus have independent effects
on a trait (Christoforou et al. 2012a; Yang et al. 2012), and
they use prior biological knowledge, facilitating a more mean-
ingful interpretation of data (Wang et al. 2010). Therefore, if
the genetic signals underlying gF and gC, two highly heri-
table and polygenic traits, cluster in known biological path-
ways, it should be possible to use pathway-based analyses
to identify which biological processes aremost strongly impli-
cated in these subcomponents of g. We particularly wanted
to determine whether gF and gC could be differentiated at
the level of biological pathways or functions as they have
been shown to be distinct in terms of development and brain
structure. Taking a ‘bottom-up’ approach (Liu et al. 2007), we
analyzed two GWAS datasets using both single-marker and
gene-based analyses to construct gene lists for IPA analysis.
Although some significantly enriched functions overlapped
in the two traits, the overall picture suggested distinct func-
tional enrichment profiles, supporting the gF–gC distinction
at the genetic level.
The most statistically significant finding was the enrich-
ment in gC of genes involved in synaptic depression and
LTD. This finding, which was unique to gC, also survived
the FDR multiple-testing correction at the more conserva-
tive 0.05 threshold and the application of more stringent
replication criteria for the construction of gene lists. It was
also the top finding when the pathway analysis included
non-CNS-related tissue types and conditions. Long-term
depression and LTP are themajor forms of long-lasting synap-
tic change in the mammalian brain (Collingridge et al. 2010).
Long-term depression is involved in synaptic pruning during
development (Peineau et al. 2007) and is thus important in
adult neuroplasticity. Synaptic LTD is mediated by the effect
of L-glutamate and other neurotransmitters on several types
of receptors. The resulting synaptic plasticity is necessary for
hippocampus-dependent learning and memory, certain types
of behavioral flexibility and novelty detection (Collingridge
et al. 2010). Long-term depression deficits have been asso-
ciated with reduced working memory and reversal of mem-
ory performance in rats. Studies focusing on medial tem-
poral lobe regions have revealed a role of LTD in memory
stabilization (in the amygdala) (Migues et al. 2010) and recog-
nition memory (in the perirhinal cortex) (Winters & Bussey
2005), implicating LTD in the development and maintenance
of knowledge representations.
For gF, the association signal was less striking in terms of
statistical significance. gF was predominantly characterized
by genes that control the quantity, morphology and integrity
of neurons and synapses. These factors affect the quality and
efficiency of neuronal signaling (Brown et al. 2008), which,
in turn, affect cognition, as indicated by reduced activation
in individuals with higher cognitive ability (Prat et al. 2007;
Reichle et al. 2000). As gF declines in cognitive aging, the
enrichment of these functions is consistent with the decline
in synapse number, brain volume and white matter integrity
in the aging brain (Fjell et al. 2009; Morrison & Hof 1997;
Walhovd et al. 2011; Westlye et al. 2010).
Only four function annotations were common to both
traits. These were related to development and structural
aspects (e.g. microtubule dynamics and dendrite formation),
which play central roles in synapse formation and are thus
likely to be important for cognitive function (Bramham et al.
2010). The genes leading to enrichment of three of these
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functions were different for gF and gC, reflecting the gain of
information that gene set or pathway-based approaches offer
by enabling the identification of overlap between related traits
or replication of the same trait.
The function annotation ‘schizophrenia’ was also signifi-
cantly enriched in gF and gC, indicating that the identified
genes have also been implicated in schizophrenia by other
studies. A polygenic risk score for schizophrenia was recently
shown to be associated with lower IQ at age 70 and greater
decline in IQ level in one of the CAGES cohorts (Mcintosh
et al. 2013), confirming previous observations at the single
candidate level of a genetic relation between general cog-
nition and schizophrenia (Toulopoulou et al. 2010). Further-
more, enrichment of the terms ‘behavior’, ‘cognition disor-
ders’ and ‘cognitive impairment’ suggests that the genes
identified here have been implicated in other studies of cogni-
tion. Finally, annotations relating to ‘Cardiovascular Disease’
ranked in the top two in both gF and gC. Cognitive dysfunc-
tion is well documented in patients with cardiovascular dis-
ease (Vogels et al. 2007).
The heritability for gF and gC are similar (Davies et al.
2011), but the strength of association, extent of replication
and strength of enrichment were all greater for gC than
for gF. There are several possible reasons for this. First,
gF may be more heterogeneous at the phenotype level.
While gC was defined as the standardized score of a single
measure in each sample, gF estimation was based on a
hierarchical principal component analysis from an array of
specific measures. The idea that the psychometric structure
of gF ismore heterogeneous is consistent with anothermajor
model of intelligence (Johnson & Bouchard 2005; Vernon
1964), in which verbal abilities are retained as a single second
stratum component, whereas fluid abilities are separated into
perceptual and mental rotation skills, thus reflecting higher
phenotypic complexity. Second, assessment of gF was not
based on identical subsets of specific tests in NCNG and each
of the CAGES subsamples. However, the different batteries
of cognitive tests yield almost identical estimates of general
intelligence (Johnson et al. 2004). Third, the age differences
between the samples could have a differential effect, given
that gF decreases with age while gC is relatively stable, even
though the correlation between them increases with age
(Li et al. 2004). Finally, the difference in enrichment profiles
may be magnified by gene-length bias, given that a stronger
association was identified for gF when IPA was re-run using
the genes that passed the more stringent criteria.
The main complicating factor in this and other studies of
brain-related traits is gene-length bias, as it presents an ana-
lytical ‘Catch-22’. While it is important to correct genes for
their length, or equivalently, the number of SNPs tested,
to control for false findings, doing so risks over-penalizing
and thus eliminating the most relevant candidate genes
and therefore pathways for intelligence. It is recognized
that gene length is related to functional complexity (Xu
et al. 2006), and it is known that brain-expressed genes
involved in relevant neuronal processes and/or associated
with autism and intellectual disability are substantially longer
(King et al. 2013; Michaelson et al. 2012). Also, it has been
suggested that longer genes are larger targets and therefore
more prone to random mutation and are subject to different
transcriptional mechanisms that may be functionally relevant
to brain-related traits (King et al. 2013; Solier et al. 2013).
Thus, in order to balance the competing Type I and II error
rates, we focused our analysis on a well-accepted and rec-
ommended discovery-replication approach (Jia et al. 2011),
running the replication in one of the largest samples of its
kind (the CAGES). Strict replication criteria were used in the
single-marker analyses (Konig 2011). For the gene-based anal-
yses, a robust permutation-based approach, which accounts
for LD structure and SNP number, was used to select genes
for replication, the criteria for which were subsequently
relaxed to avoid over-penalizing the larger, more relevant
genes. In order to then assess the robustness of these find-
ings, IPA was also run on genes that survived the more strin-
gent approach that corrects for SNP number. As the power
of the IPA analysis was greatly compromised by the ∼sixfold
reduction in the number of genes available for the analy-
sis, it was not surprising that the evidence for the genetic
distinctiveness of the two traits was weaker. Nevertheless,
the main distinguishing features between gF and gC were
upheld. This suggests that the true genetic architecture of
these two traits may lie in the middle, and is inaccessible
using current approaches which either ignore or over-penalize
for the length of the gene.
As larger consortia form and pathway analyses continue to
improve, a better understanding of the genetic architecture of
gF and gC will emerge (Khatri et al. 2012; Lencz et al 2014).
Meanwhile, our study serves as a starting point, supporting
the gF–gC distinction at the genetic level and critically con-
vergingwith the findings of developmental and cognitive neu-
roscience studies. The specific function annotations, or path-
ways, identified are worthy of further replication and interro-
gation, using, for example, ‘top-down’ approaches such as
gene set enrichment analysis (Fernandes et al. 2013) to test
specific gene sets constructed on the basis of these findings.
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Figure S1: Manhattan (left) and quantile–quantile (QQ;
right) plots of (a) fluid and (b) crystallized intelligence in the
NCNG. The genomic inflation factor, based on the median 𝜒2,
as implemented in PLINK, is 1 for both fluid and crystallized
intelligence. The blue line in the Manhattan plots indicates
the suggestive P=1×10−5 threshold, whereas the red line
indicates the traditional genome-wide 5×10−8 threshold.
Figure S2: Histogram of number of function annotations
relating to each general function for gF (top) and gC (bottom).
The predominant function for gF (‘quantity’) and gC (‘LTD’)
are indicated.
Dataset S1: Results of single-marker analyses.
Dataset S2: Results of gene-based analyses.
Dataset S3: Ingenuity Pathway Analysis results.
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